Isocitrate dehydrogenase mutations in leukemia Journal Article


Authors: McKenney, A. S.; Levine, R. L.
Article Title: Isocitrate dehydrogenase mutations in leukemia
Abstract: Recent genome-wide discovery studies have identified a spectrum of mutations in different malignancies and have led to the elucidation of novel pathways that contribute to oncogenic transformation. The discovery of mutations in the genes encoding isocitrate dehydrogenase (IDH) has uncovered a critical role for altered metabolism in oncogenesis, and the neomorphic, oncogenic function of IDH mutations affects several epigenetic and gene regulatory pathways. Here we discuss the relevance of IDH mutations to leukemia pathogenesis, therapy, and outcome and how mutations in IDH1 and IDH2 affect the leukemia epigenome, hematopoietic differentiation, and clinical outcome.
Journal Title: Journal of Clinical Investigation
Volume: 123
Issue: 9
ISSN: 0021-9738
Publisher: American Society for Clinical Investigation  
Date Published: 2013-09-03
Start Page: 3672
End Page: 3677
Language: English
DOI: 10.1172/jci67266
PROVIDER: scopus
PMCID: PMC3754251
PUBMED: 23999441
DOI/URL:
Notes: --- - Cited By (since 1996):1 - "Export Date: 1 October 2013" - "CODEN: JCINA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    776 Levine